AMRN:NASDAQ
Amarin Corporation PLC
$11.94
arrow_downward
-1.08%(-0.13) 1D
Oct 7, 9:41:22 AM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AMRN...
Open
$12.00
High
$12.00
Low
$11.86
Mkt. cap
257.63M
Avg. vol.
76.23K
Volume
360.00
52-wk high
$20.90
52-wk low
$11.83
EPS
-$1.30
Beta
0.76
Shares outstanding
21.12M
No. of employees
80
Open
$12.00
High
$12.00
Low
$11.86
Mkt. cap
257.63M
Avg. vol.
76.23K
Volume
360.00
52-wk high
$20.90
52-wk low
$11.83
EPS
-$1.30
Beta
0.76
Shares outstanding
21.12M
No. of employees
80
News stories
From web sources and news partners
Fox News
·
13 minutes ago
FOX News Media CEO Suzanne Scott rings Nasdaq Closing Bell as network celebrates 30th anniversary
PR Newswire UK
·
55 minutes ago
Snorkel AI Raises $350 Million to Help Push the Frontier: NYSE Content Update
WV News
·
23 minutes ago
Financial Markets
Reuters
·
10 minutes ago
Wall St opens lower as bond yields and oil rebound; Fed minutes in focus
Profile
Amarin Corporation is an Irish-American biopharmaceutical company founded in 1993 and headquartered in Dublin, Ireland and Bridgewater, New Jersey. The company develops and markets medicines for the treatment of cardiovascular disease. It has developed the drug Vascepa, a prescription grade omega-3 fatty acid.
In July 2012, their lead-candidate drug named Vascepa received FDA-approval, competing against GlaxoSmithKline's Lovaza. Wikipedia
About Amarin Corporation PLC
CEO-
Employees80
FoundedMar 1, 1989
HeadquartersDublin, Leinster, Ireland
SectorBiotechnology
Websiteamarincorp.com